ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Preclinical Study for Liver Allograft Tolerance after Rapid Immunosuppression Withdrawal Using Cynomolgus Monkeys

H. Sakai1, E. Berglund1, S. Chaudhry1, Y. Kato1, J. Weiner1, P. Alonso-Guallart1, N. Llore1, K. Bruestle1, F. Fredriksson1, J. Stern1, D. Ekanayake-Alper1, M. Martinez2, G. Pierre1, M. Danton1, S. Kofman1, D. Ordanes1, J. Lefkowitch3, A. Iuga1, T. Kato4, M. Sykes1, A. Griesemer1

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, 2Department of Pediatrics, Columbia University, New York, NY, 3Departments of Pathology and Cell Biology, Columbia University, New York, NY, 4Department of Surgery, Columbia University, New York, NY

Meeting: 2020 American Transplant Congress

Abstract number: 468

Keywords: Liver transplantation, Preclinical trails, Tolerance

Session Information

Session Name: Tolerance

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:15pm-4:27pm

Location: Virtual

*Purpose: Operational tolerance of liver allografts occurs in highly selected patients but cannot be reliably induced. Herein, we investigated if tolerance to liver can be achieved in cynomolgus macaques after rapid immunosuppression (IS) withdrawal with non-myeloablative preparative regimens.

*Methods: 14 cynomolgus monkeys received liver transplants with or without donor bone marrow transplantation (BMT) (Table 1). Subjects received tacrolimus-based IS maintenance for 28 days and then complete withdrawal on day 55. We systematically evaluated peripheral blood chimerism, graft function and immunological status until an end-point was reached. Endpoints were graft rejection, graft-versus-host disease (GVHD), weight loss, survival >600 days or death. Protocols were modified based on outcomes.

*Results: Multilineage mixed chimerism was seen in recipients with or without BMT. Animal A(2) developed grade 1 GVHD. The addition of anti-CD2 mAb on POD1 in Group B depleted donor CD8+ T effector memory (Tmem) and prevented GVHD while permitting mixed chimerism and extended IS-free graft survival. In Group C, without BMT, mild rejection was seen long-term, even when chimerism was lost and Tmem cells recovered. Additional doses of anti-CD2 mAb on POD55 in Group D did not deplete recovered Tmem due to elicited antibodies against anti-CD2 mAb. Increased serum IL-6 levels during a period of bacterial infection correlated with the expansion of Tmem associated with a rejection crisis, while the expansion of Tmem was absent in Animal E that received anti-IL-6R mAb. PD-L1 expression on antigen-presenting cells in the liver allograft was upregulated in recipients with long-term survival.

*Conclusions: This is the first proof of concept study demonstrating long-term stable liver allograft function in nonhuman primates using a non-myeloablative treatment regimen to facilitate rapid IS withdrawal. The liver’s ability to modulate the activation of host T cells by PD-L1/PD-1 pathway may contribute to tolerance of liver allografts.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sakai H, Berglund E, Chaudhry S, Kato Y, Weiner J, Alonso-Guallart P, Llore N, Bruestle K, Fredriksson F, Stern J, Ekanayake-Alper D, Martinez M, Pierre G, Danton M, Kofman S, Ordanes D, Lefkowitch J, Iuga A, Kato T, Sykes M, Griesemer A. Preclinical Study for Liver Allograft Tolerance after Rapid Immunosuppression Withdrawal Using Cynomolgus Monkeys [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/preclinical-study-for-liver-allograft-tolerance-after-rapid-immunosuppression-withdrawal-using-cynomolgus-monkeys/. Accessed May 9, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences